查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1304163

月經痛治療市場:各類藥物，各類型，各給藥途徑，各劑型，各流通管道，各地區- 市場規模，佔有率，展望，機會分析，2023年～2030年

Menstrual Cramps Treatment Market, By Drug Class, By Type, By Route of Administration, By Dosage Form, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 205 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

市場動態

市場參與者正專注於增加無機策略，例如 月經痙攣治療的合作，預計將在預測期內推動全球月經痙攣市場的增長。

本調查的主要特徵

  • 本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球月經痛治療市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
  • 並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
  • 同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
  • 並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球月經痛治療市場的主要參與者之企業簡介。
  • 藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
  • 全球月經痛治療市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以透過全球月經痛治療市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

目錄

第1章 調查目的與前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場概況

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
  • 連貫·機遇·地圖(COM)

第3章 市場動態，法規，趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場魅力分析
    • 市場機會
  • 產品發表
  • 市場趨勢
  • 合併，收購，聯盟
  • 法規指南和遵守
  • 主要的發展
  • PEST分析
  • 技術形勢
  • 價格分析
  • 品牌分析
  • 投資與資金籌措
  • 設施的擴張

第4章 月經痛治療的全球市場:冠狀病毒(COVID-19)流行的影響

  • 政府的配合措施
  • COVID-19流行病學
  • 主要的發展

第5章 月經痛治療的全球市場:各類藥物，2018年～2030年

  • 止痛藥
  • 抗膽鹼藥
  • 非類固醇消炎劑
  • 血液循環促進藥
  • 其他(特別黃體激素劑)

第6章 月經痛治療的全球市場:各類型，2018年～2030年

  • 原發性經痛
  • 續發性經痛

第7章 月經痛治療藥的全球市場:各給藥途徑，2018年～2030年

  • 口服劑
  • 注射劑
  • 局部
  • 其他(子宮內，其他)

第8章 月經痛治療的全球市場:各劑型，2018年～2030年

  • 錠劑
  • 膠囊劑
  • 懸浮液
  • 其他(經皮吸收貼片，其他)

第9章 月經痛治療的全球市場:各流通管道，2018年～2030年

  • 醫院藥局
  • 零售藥局
  • 線上藥局

第10章 月經痛治療的全球市場:各地區，2018年～2030年

  • 北美
  • 美國
  • 加拿大
  • 南美
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他南美國家
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 中東
  • GCC
  • 以色列
  • 其他中東
  • 非洲
  • 北非
  • 中非
  • 南非

第11章 競爭情形

  • Pfizer, Inc.
  • Ingelheim International GmbH
  • Bayer AG
  • Abbott
  • Cipla Inc
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Johnson & Johnson Services, Inc.
  • Reddy's Laboratories Ltd
  • Almatica Pharma LLC.
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Eisen Pharmaceutical Co.(Pvt.)Ltd
  • Emcure Pharmaceuticals
  • AbbVie
  • Sparsha Pharma International Pvt Ltd.
  • Hope Medicine(南京市)Co., Ltd

第12章 章節

  • 調查手法
  • 關於出版社
簡介目錄
Product Code: CMI5760

Menstrual cramps (dysmenorrhea) are throbbing or cramping pains in the lower abdomen. Many women have menstrual cramps just before and during their menstrual periods. Conditions such as endometriosis or uterine fibroids can cause menstrual cramps. Symptoms occurred like aching pain in lower abdomen, a feeling of pressure in belly, pain in hips, lower back, and inner thighs. To treat menstrual cramps, over-the-counter pain relievers such as NSAID's like ibuprofen (Advil), Naproxen sodium (Aleve) are used. Hormonal antagonists drugs such as MYFEMBREE (Pfizer) also used for the treatment of menstrual cramps.

Market Dynamics

Market players in the market are focusing on ncreasing inorganic strategies such as collaboration for menstrual cramp treatment is expected to drive the the global menstrual cramp market growth over the forecast period. For instance, on April 10, 2018, AbbVie, a global research and development-based biopharmaceutical company, and Neurocrine Biosciences, announced PDUFA (Prescription Drug User Fee Act) for Elagolix in endometriosis-associated pain.. Elagolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist. It is administered orally, and is a short-acting molecule that blocks endogenous GnRH receptors in the pituitary gland.

Increasing prevalence of menstrual cramps is expected to drive the market growth over the forecast period. For instance, on January 14, 2022, article published by MDPI, stated that a study was conducted in Europe's Romania in prospective, analytical, observational and took place between 7 November 2019 and 30 January 2020. This study included a population of 1720 from five university centers throughout the country. Out of 1,720 participants, 1,349 (78.4%) had dysmenorrhea. The prevalence of dysmenorrhea, ranging from 16% to 91% has been reported. The most widely used drugs were non-steroidal anti-inflammatory drugs, utilized by 741 students (54.9%) has been reported.

Moreover, according to article published by International Journal of Womens Health, a study was conducted in Southern Ethiopia, the prevalence of primary dysmenorrhea among all the female students is 70% of population who reported.

Key features of the study:

  • This report provides in-depth analysis of the global menstrual cramps treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global menstrual cramps treatment market based on the following parameters company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Pfizer Inc., Ingelheim International GmbH., Bayer AG, , Cipla Inc, Teva Pharmaceutical Industries Ltd., Sanofi, Johnson & Johnson Services, Inc., Dr. Reddy's Laboratories Ltd, Almatica Pharma LLC., F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Eisen Pharmaceutical Co. (Pvt.) Ltd., Emcure Pharmaceuticals, AbbVie., Sparsha Pharma International Pvt Ltd, Hope Medicine (Nanjing) Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global menstrual cramps treatments market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global menstrual cramps treatments market

Detailed Segmentation:

  • Global Menstrual Cramp Treatment Market, By Drug Class:
    • Analgesics
    • Anticholinergic
    • Non-steroidal anti-inflammatory drugs (NSAIDs)
    • Haematinics
    • Others (Progestins, Among others)
  • Global Menstrual Cramp Treatment Market, By Type:
    • Primary Dysmenorrhea
    • Secondary Dysmenorrhea
  • Global Menstrual Cramp Treatment Market, By Route of Administration:
    • Oral
    • Injectable
    • Topical
    • Others (Intrauterine, Others)
  • Global Menstrual Cramp Treatment Market, By Dosage Form:
    • Tablet
    • Capsules
    • Suspension
    • Others (Transdermal Patch, Among others)
  • Global Menstrual Cramp Treatment Market, By Distribution channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Menstrual Cramps Treatment Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Pfizer Inc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Ingelheim International GmbH PerkinElmer Inc.
    • Bayer AG
    • Abbott.
    • Cipla Inc
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • Johnson & Johnson Services, Inc.
    • Dr. Reddy's Laboratories Ltd
    • Almatica Pharma LLC.
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline Plc
    • Eisen Pharmaceutical Co. (Pvt.) Ltd.
    • Emcure Pharmaceuticals
    • AbbVie.
    • Sparsha Pharma International Pvt Ltd.
    • Hope Medicine (Nanjing) Co., Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Type
    • Market Snapshot, By Route of administration
    • Market Snapshot, By Dosage Form
    • Market Snapshot, By Distribution channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
  • Product Launches
  • Market Trends
  • Merger, Acquisition, Collaborations
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • Technology Landscape
  • Pricing Analysis
  • Brand Analysis
  • Investments and Funding
  • Facility Expansions

4. Global Menstrual Cramps Treatment Market- Impact of Coronavirus (Covid-19) Pandemic

  • Government Initiatives
  • COVID-19 Epidemiology
  • Key Developments

5. Global Menstrual Cramps Treatment Market, By Drug Class, 2018-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Analgesics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Anticholinergics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Non-steriodal anti-inflammatory drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Haematinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others (Progestins, Among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global Menstrual Cramps Treatment Market, By Type, 2018 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Primary Dysmenorrhea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Secondary Dysmenorrhea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global Menstrual Cramps Treatment Market, By Route of administration, 2018 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segments Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others (Intrauterine, Among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Global Menstrual Cramps Treatment Market, By Dosage Form, 2018 - 2030, (US$ Million)

  • Tablet
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Capsules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Suspension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others (Transdermal Patch, Among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

9. Global Menstrual Cramps Treatment Market, By Distribution channel, 2018 - 2030, (US$ Million)

  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

10. Global Menstrual Cramps Treatment Market, By Region, 2018 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Pfizer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cipla Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson Services, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Reddy's Laboratories Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Almatica Pharma LLC.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GlaxoSmithKline Plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eisen Pharmaceutical Co. (Pvt.) Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Emcure Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AbbVie
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sparsha Pharma International Pvt Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hope Medicine (Nanjing) Co., Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

12. Section

  • Research Methodology
  • About Us